In the 3rd year of the program 8 new molecular diagnostic services have been introduced to clinic in the management of breast-, lung-, colorectal cancers as well as in GIST and melanoma. Two patents have been filed for innovative modulation of mito/motogenic signaling pathways in cancer cells. In preclinical models of human cancer a functional imaging technique was developed to detect vascular eff ects of erythropoietin. Using a genomic approach, the sequential changes in human melanoma during systemic dissemination were determined revealing several novel potential prognostic factors and some interesting novel targets for therapy.
|Translated title of the contribution||Developments in cancer management by innovative genomics. 2008 report of the National Cancer Consortium|
|Number of pages||14|
|Publication status||Published - Dec 1 2009|
ASJC Scopus subject areas